| abstract |
(57) [Summary] (with correction) [PROBLEMS] To provide a novel G protein-coupled receptor that specifically acts on an extracellular signal transduction molecule. Further G Since activation or inhibition of a protein-coupled receptor may have therapeutic consequences, its related agonists and antagonists are also provided. A polynucleotide and polypeptide sequence are described. The polypeptide sequence is one or more of (a) a polypeptide having a deduced amino acid sequence translated from a polynucleotide sequence of a particular sequence, or a variant, fragment, homolog, analog or derivative thereof; (B) Includes polypeptides of related sequences, or variants, fragments, homologs, analogs or derivatives thereof. An agonist or antagonist of the polypeptide may be inflammatory, It is used in the therapeutic fields such as cancer, dermatology, metabolic diseases, and anti-infection. |